3M™ Littmann® CORE Digital Stethoscope
Trusted Littmann performance combined with Eko's digital innovation and AI
Company profile
Company profile
Eko brings together stethoscopes, powerful software, and AI-supported analysis to elevate the way we detect cardiovascular disease.
Company description Eko Health official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas · Embedded · Hybrid deployment with recorded integration context.
Company milestones
CMS finalized OPPS payment for SENSORA Platform expanding reimbursement in hospital-associated outpatient care; launched AI solution for veterinary care with Boehringer Ingelheim; published TRICORDER Study in The Lancet; DAMSUN-HF Study in Sub-Saharan Africa
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Trusted Littmann performance combined with Eko's digital innovation and AI
Modern stethoscope replacement with 3-lead ECG, AI insights, and 8x sound improvement
Digital attachment to upgrade existing stethoscopes with Eko technology
FDA-cleared AI for detecting murmurs, AFib, and low ejection fraction
FDA-cleared AI algorithms for detecting murmurs, AFib, and low ejection fraction
Telehealth-compatible platform for remote cardiac and pulmonary auscultation
Purpose-built AI solution for detecting heart murmurs in veterinary care
Enterprise AI platform for cardiac disease detection across health systems
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
European heart journal. Digital health · Mar 1, 2026
Correction to: External evaluation of a commercial artificial intelligence-augmented digital auscultation platform in valvular heart disease detection using echocardiography as reference standard (Int J Cardiol. 2025;419:132653).International journal of cardiology · Aug 1, 2025
Automated Detection of Reduced Ejection Fraction Using an ECG-Enabled Digital Stethoscope: A Large Cohort Validation.JACC. Advances · Mar 1, 2025
Development and Evaluation of a Deep Learning-Based Pulmonary Hypertension Screening Algorithm Using a Digital Stethoscope.Journal of the American Heart Association · Feb 4, 2025
Foundation models for cardiovascular disease detection via biosignals from digital stethoscopes.NPJ cardiovascular health · Oct 11, 2024
Clinical validation
NCT06155643 · Mentioned · RECRUITING
Triple Cardiovascular Disease Detection With an Artificial Intelligence-enabled StethoscopeNCT05987670 · Mentioned · ACTIVE NOT RECRUITING
Regulatory
K251494 · 510k · Aug 12, 2025
Eko Low Ejection Fraction Tool (ELEFT)K233409 · 510k · Mar 28, 2024
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Providers using Eko vs traditional stethoscope
CORE 500 compared to traditional stethoscope
Problem statement addressed by Eko
Detecting heart failure with reduced ejection fraction in Sub-Saharan Africa
Specialist-level heart failure detection using Eko's AI-enabled stethoscope
Improving efficiency in virtual exams with high-quality auscultation
Efficiency in virtual exams is as good as in-person visits
Delivering high-acuity care at home using Eko's telehealth platform
Successfully delivers high-acuity care at home
Real-world evaluation of AI-enabled stethoscopes in primary care
Increased detection when Eko AI-enabled stethoscopes are used in primary care
Detecting heart failure with reduced ejection fraction in resource-limited settings
Specialist-level heart failure detection using Eko's AI-enabled stethoscope
Catalyzing the evolution of patient experience through digital patient care technologies
Bringing care to the patient through technologies like Eko
Real-world evaluation of AI-enabled stethoscopes in primary care settings
Increased detection when Eko AI-enabled stethoscopes are used in primary care
Deploying AI-assisted cardiac detection in rural Mississippi
Partnership to deploy AI-assisted cardiac detection in rural setting
05 · Leadership
Leadership profiles and professional links from the current Company record.
06 · Company updates
Recent articles published on Eko Health's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies applying AI to cardiovascular disease detection, ECG/EKG analysis, heart failure management, cardiac imaging, arrhythmia detection, or cardiovascular risk assessment. Includes AI-powered cardiac diagnostics, non-invasive hemodynamic monitoring, and tools for early detection and personalized management of heart conditions.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.